<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="729103" id="root" date="1997-07-15" xml:lang="en">
<title>USA: FDA panel OKs Bristol-Myers' Excedrin for migraine.</title>
<headline>FDA panel OKs Bristol-Myers' Excedrin for migraine.</headline>
<dateline>BETHESDA, Md. 1997-07-15</dateline>
<text>
<p>A U.S. Food and Drug Administration advisory panel on Tuesday voted unanimously that Bristol-Myers Squibb's Excedrin Extra-Strength is effective for the temporary relief of migraine headache pain.</p>
<p>Migraine headaches affect 20-25 million Americans each year, three-quarters of them women.</p>
<p>A majority of the panel, 14 of the 17, felt it was safe as well. But the committee wanted to strengthen Excedrin E-S labeling to give guidance to consumers on how to differentiate among migraines and other headaches.</p>
<p>The FDA is not bound by its panels' advice, but usually follows it.</p>
<p>Excedrin E-S, sold since 1978, is the third-biggest pain reliever in the United States. BMS argued that since most migraineurs self-treat, an over-the-counter (OTC) drug is appropriate.</p>
<p>In a survey of migraineurs, BMS found that two-thirds of men and 57 percent of women use OTC's only.</p>
<p>&quot;Self-treatment is the norm, not the exception,&quot; said Richard Lipton, a headache specialist with the Albert Einstein College of Medicine and a BMS representative.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C13">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
  <code code="C21">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
  <code code="GCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
  <code code="GHEA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-07-15"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-07-15"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-07-15"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="BETHESDA, Md."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
